Home Archives Avanos Medical, Inc. Announces First Quarter 2026 Results Avanos Medical, Inc. Announces First Quarter 2026 ResultsMay 5, 2026 B Delivered double-digit organic growth led by Specialty Nutrition Systems segment Generated $0.11 of diluted earnings per share and $0.22 of adjusted diluted earnings per… Login to continue reading Login Sign up for complimentary access Sign Up Now Close posteditor Articles: 21727 Previous Post FDA Grants Fast Track Designation for CS-1103, a First-in-class Small Molecule to Reverse Acute Intoxication from Fentanyl Next Post Cambridge Global Advisors Expands Border & National Security Team with Six New Senior Advisors